Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YH14618 in Lumbar Degenerative Disc Disease
NCT02320019Phase 2Completed
- Sponsor
- Yuhan
- Start
- Mar 2015
- Primary completion
- Apr 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of vicatertide in lumbar degenerative disc syndrome (LDDS), sponsored by Yuhan. Started Mar 2015; status: completed.
02
Drugs
vicatertide
03
Conditions
lumbar degenerative disc syndrome (LDDS)
Beyond the preview
Go deeper on NCT02320019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02320019.